Erratum: Effects of awake prone position vs. usual care on acute hypoxemic respiratory failure in patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials
- 1Department of Orthopedics, Clinical Medical College of Yangzhou University, Yangzhou, China
- 2Department of Orthopedics, Graduate School of Dalian Medical University, Dalian, China
- 3Department of Anesthesiology, Children's Hospital of Nanjing Medical University, Nanjing, China
- 4Department of Respiratory, Clinical Medical College of Yangzhou University, Yangzhou, China
- 5Department of Critical Care Medicine, Clinical Medical College of Yangzhou University, Yangzhou, China
- 6Department of Orthopedics, Regenerative Medicine Engineering Technology Research Center of Yangzhou, Yangzhou, China
Background: Previous studies have shown that an awake prone position may be beneficial for the treatment of acute respiratory distress syndrome (ARDS) or acute hypoxic respiratory failure (AHRF) in patients with COVID-19, but the results are not consistent, especially in terms of oxygenation outcomes and intubation rate. This systematic review and meta-analysis assessed the effects of the awake prone position on AHRF in patients with COVID-19 with all randomized controlled trials (RCTs).
Methods: An extensive search of online databases, including MEDLINE, Embase, Web of Science, and Cochrane Central Register of Controlled Trials from 1 December 2019 to 30 October 2022, with no language restrictions was performed. This systematic review and meta-analysis are based on the PRISMA statement. We only included RCTs and used the Cochrane risk assessment tool for quality assessment.
Results: Fourteen RCTs fulfilled the selection criteria, and 3,290 patients were included. A meta-analysis found that patients in the awake prone position group had more significant improvement in the SpO2/FiO2 ratio [mean difference (MD): 29.76; 95% confidence interval (CI): 1.39–48.13; P = 0.001] compared with the usual care. The prone position also reduced the need for intubation [odd ratio (OR): 0.72; 95% CI: 0.61 to 0.84; P < 0.0001; I2 = 0%]. There was no significant difference in mortality, hospital length of stay, incidence of intensive care unit (ICU) admission, and adverse events between the two groups.
Conclusion: The awake prone position was a promising intervention method, which is beneficial to improve the oxygenation of patients with ARDS or AHRF caused by COVID-19 and reduce the need for intubation. However, the awake prone position showed no obvious advantage in mortality, hospital length of stay, incidence of ICU admission, and adverse events.
Systematic review registration: International Prospective Register of Systematic Reviews (PROSPERO), identifier: CRD42022367885.
Introduction
During the early phase of the COVID-19 epidemic, the number of patients soared, which brought great challenges to the hospital resources and intensive care unit (ICU) ability. The awake prone position is widely recommended for its potential benefits such as ease of implementation, low risk, and reduced ICU admission requirement (1, 2). Prone position, non-invasive mechanical ventilation, and high-flow oxygen are regarded as feasible and safe interventions in acute hypoxic respiratory failure (AHRF) or acute respiratory distress syndrome (ARDS) (3, 4). The first proposal suggested that the prone position should be used to treat COVID-19, and they believe that the prone position can reduce the need for endotracheal intubation and invasive mechanical ventilation (5).
Previous studies have shown that the awake prone position can improve oxygenation and reduce mortality in patients with ARDS (6, 7). Prone position can increase alveolar ventilation, reduce shunt, and improve ventilation/perfusion ratio (8). The prone position can also recruit the alveoli in the gravity-dependent area (9) and reduce ventilator-associated lung injury (10). Although the prone position is more and more widely used, there is no unified conclusion about its effect on COVID-19 patients with AHRF. On the other hand, the prone position may lead to some negative effects such as reducing comfort and increasing diaphragm fraction (11).
Some observational studies also found that the awake prone position can improve oxygenation in patients with ARDS or AHRF caused by COVID-19 (12–15). However, the effect on intubation rate and mortality of patients has not reached a unified and clear conclusion. In addition, some randomized controlled trials (RCTs) have come to contradictory conclusions in these areas. In the recent three systematic reviews and meta-analyses (16–18), Li et al. reported that the awake prone position can reduce the need for intubation, but have no significant effect on mortality in COVID-19-associated patients with AHRF (16). Kang et al. found that the prone position can reduce the intubation rate and mortality of patients (17). Fazzini et al. reported that the prone position can improve oxygenation and mortality, but show no significant effect on intubation rate and ICU admission (18).
A systematic review and meta-analysis of RCTs showed that the prone position could effectively improve oxygenation and reduce the intubation rate in patients with COVID-19 (19). However, this study has some limitations. First, the number of studies that can be included is small and the heterogeneity is high. Second, this study did not compare whether there is a significant improvement in oxygenation before and after prone position intervention. In addition, after the completion of the system review, four new RCTs (20–23) were published recently. The purpose of this study was to further explore the clinical outcome of awake prone position on patients with ARDS or ARHF caused by COVID-19. Primary outcomes included oxygenation, intubation rate, and secondary outcomes included mortality, hospital length of stay (LOS), ICU admission, and incidence of adverse events.
Methods
This systematic review and meta-analysis are based on the PRISMA statement (24) and have been registered on the International Prospective Register of Systematic Reviews (PROSPERO) with the registered ID: CRD42022367885 on 20 October 2022.
Search strategy
Two examiners (QP and SY) completed an extensive literature search through online databases independently from 1 December 2019 to 30 October 2022, including MEDLINE, Embase, Web of Science, and Cochrane Central Register of Controlled Trials, with no language restrictions. The search strategy of PubMed was realized by the combination of Medical Subject Headings (MeSH) or free words, including (prone position) and (ARDS or hypoxemic respiratory failure) and (COVID-19 or SARS-CoV-2). The detail of the retrieval strategy is listed in Appendix 1 of the Supplementary material. The search strategies of different databases were adjusted according to the specific situation.
Study selection
After the completion of the literature search, all duplicate studies were deleted, and then two examiners independently reviewed the studies according to the inclusion and exclusion criteria, which were established according to the PICOS principle (25).
Inclusion criteria: (1) population (P): The study population was COVID-19 patients with ARDS or AHRF, age≥18 years old, (2) intervention (I): awake prone position, (3) comparator (C): to compare the difference in clinical outcomes between patients in the prone position and usual care groups, (4) outcome (O): Primary outcomes included oxygenation, intubation rate, and secondary outcomes included mortality, hospital length of stay, ICU admission, and incidence of adverse events, and (5) study design (S): RCTs.
Exclusion criteria: (1) review, meta-analysis, experimental protocol, case report, and observational study, (2) study on the intervention of intubated patients in the prone position, (3) did not report the outcomes we need, (4) insufficient data or not available through calculation, and (5) non-randomized controlled trials.
Data extraction and quality assessment
Two examiners extracted data according to the form designed for this systematic review independently and then checked it by the third inspector to ensure accuracy and completeness. The data extracted from the inclusion study included first author, year, study design, study setting, participant characteristics, oxygen delivery, outcomes, and conclusions (Table 1).
The Cochrane Collaboration Risk of Bias tool (26) was used to assess the quality of included RCTs. This tool assesses bias risk through seven aspects, including random sequence generation, allocation concealment, blinding of participants or personnel, blinding of outcome assessment, incomplete outcome data, selective reporting, and other biases. Each potential source of bias was classified as high, low, or unclear. All divergences in the process of data extraction and quality assessment were resolved through discussions among the three reviewers.
Data analysis
The oxygenation outcomes and hospital LOS were continuous. Intubation rate, mortality, incidence of ICU admission, and adverse events were dichotomous. We used mean difference (MD) to evaluate continuous outcomes and odds ratio (OR) to evaluate dichotomous outcomes. In continuous outcomes, the median/inter-quartile range (IQR) is converted to the mean and standard deviation by statistical formula if the mean and standard deviation are not available (27, 28). GetData Graph Digitizer 2.26 was used to extract mean values and standard deviations when data exist in the form of figures or charts. We use the method reported by the Cochrane Handbook to calculate the mean and standard deviation of baseline changes (29).
This systematic review compared the effects of prone position and usual care on acute hypoxic respiratory failure in patients with COVID-19. All the included studies were homogeneous. Meta-analysis was carried out using Review Manager 5.4 software (version 5.4 Cochrane Collaboration), and the results were presented in the form of forest plots. The continuous outcomes used inverse variance (IV), and the dichotomous outcomes used Mantel–Haenszel (M–H) to calculate the overall effect with a 95% confidence interval (CI). I2 was used to assess heterogeneity between studies, I2 < 50% is considered low heterogeneity and I2 > 50% was considered moderate to high heterogeneity (30). The fixed effect model was used for low heterogeneity, and the random effect model was used for moderate to high heterogeneity (31). The threshold for significance for p-values was 0.05.
Results
Study selection and study characteristics
After the study search was completed and all duplicates were deleted, a total of 612 studies entered the screening process, and 14 studies and a total of 3,290 patients were finally included in this meta-analysis (20–23, 32–40) (NCT04853979). The process of study screening is shown in Figure 1. All 14 included studies were RCTs, five single-center studies, and nine multi-center studies. They have explored the effect of the prone position on ARDS or AHRF in patients with COVID-19. No incomplete or selective results were reported in the included RCTs, and all the characteristics and data information are presented in Table 1.
Risk of bias assessment
Eight of the 14 studies were considered to have a high risk of bias (21, 35–39). Two studies showed a high risk of bias in the allocation concealment (35, 36), and seven studies showed a high risk of bias in the blinding of participants or researchers (21, 35, 37–39). The rest of the studies were assessed as low bias risk because they had low bias risk in almost all areas. The result of the assessment of bias risk is shown in Figures 2A, B.
![www.frontiersin.org](https://www.frontiersin.org/files/Articles/1120837/fmed-10-1120837-HTML-r1/image_m/fmed-10-1120837-g002.jpg)
Figure 2. Assessment of risk of bias based on the Cochrane risk of bias tool. (A) Risk of bias graph; (B) Risk of bias summary.
Oxygenation outcome
Five studies including 1,145 patients reported the SpO2/FiO2 (S/F) ratio before and after the prone position (21, 23, 33, 35, 39), and the results of the meta-analysis showed that there is a significant difference between them (Figure 3A), MD = −34.01 (95% CI: −49.73 to −18.29; P < 0.0001), indicating that prone position can significantly improve S/F ratio in patients with COVID-19 with ARDS or AHRF. I2 = 96% indicated that there is a high heterogeneity among studies.
![www.frontiersin.org](https://www.frontiersin.org/files/Articles/1120837/fmed-10-1120837-HTML-r1/image_m/fmed-10-1120837-g003.jpg)
Figure 3. Primary outcome: forest plot of SpO2/FiO2 ratio in the random-effects model. (A) pre-PP vs. post PP; (B) prone vs. US; PP, prone position; US, usual care; SD, standard deviation; IV, inverse variance; CI, confidence interval.
The baseline change data of the S/F ratio between the prone position and usual care group can be obtained from the same five studies (21, 23, 33, 35, 39). The summary results showed that there is a significant difference between the two groups (Figure 3B), MD = 29.76 (95% CI: 11.39–48.13; P = 0.001). The results found that the prone position can significantly improve the S/F ratio of patients with COVID-19 compared with the usual care group. I2 = 96% also showed high heterogeneity among studies.
Intubation
A total of 13 RCTs (20–23, 32, 34–40) (NCT04853979) including 3,263 patients, reported the need for intubation between the prone position group and the usual care group, and one study (35) reported that nobody needs to be intubated in both groups. The summary results showed that there is a significant difference between the two groups. Compared with the usual care group, patients had a significantly lower intubation rate in the prone position group, OR = 0.72 (95% CI: 0.61–0.84; P < 0.0001; I2 = 0%) (Figure 4). I2 = 0% indicated low heterogeneity. In addition, a subgroup analysis of the intubation rate according to the average time of prone position per day (< 8 h >8 h; P = 0.18), and ICU vs. non-ICU (P = 0.61), there was no significant difference between the two groups (Figures S1, S2 in Supplementary material). On the other hand, the subgroup analysis of the intubation rate according to oxygen delivery shows that the awake prone position group had a significantly lower intubation rate compared with the usual care group in patients with a high-flow nasal cannula (HFNC) or non-invasive ventilation (NIV), OR = 0.65 (95% CI: 0.54–0.78; P < 0.00001; I2 = 0%), but this difference was not found in the patients with low flow or conventional oxygen therapy (COT), OR = 1.05 (95% CI: 0.59–1.86; P = 0.87; I2 = 0%) (Figure S3 in Supplementary material).
![www.frontiersin.org](https://www.frontiersin.org/files/Articles/1120837/fmed-10-1120837-HTML-r1/image_m/fmed-10-1120837-g004.jpg)
Figure 4. Primary outcome: forest plot of intubation rate in fixed effects model. US, usual care; M–H, Mantel–Haenszel; CI, confidence interval.
Mortality
A comprehensive analysis of the mortality of 3,223 patients in the two groups reported by 10 RCTs (20–23, 32, 34, 36–40) (NCT04853979) showed that the 95% confidence interval of the odds ratio exceeded the limit of no effect, OR = 0.88 (95% CI: 0.74–1.06; P = 0.17; I2 = 0%), There was no statistically significant difference between the two groups (Figure 5). I2 = 0% indicated low heterogeneity.
![www.frontiersin.org](https://www.frontiersin.org/files/Articles/1120837/fmed-10-1120837-HTML-r1/image_m/fmed-10-1120837-g005.jpg)
Figure 5. Secondary outcome: forest plot of mortality in fixed effects model. US, usual care; M–H, Mantel–Haenszel; CI, confidence interval.
Hospital LOS
Eight RCTs (22, 23, 32, 34–36, 38, 39) were reported at the hospital LOS in the prone position and usual care groups, including a total of 2267 patients. The forest plot showed that the 95% confidence interval crosses the threshold of ineffectiveness, and there is no statistical difference between the two groups in hospital LOS, MD = −0.36 (95% CI: −1.39 to 0.66; P = 0.49) (Figure S4 in Supplementary material). I2 = 98% indicated high heterogeneity.
ICU admission
Only four RCTs (22, 34–36) reported the incidence of ICU admission including 438 patients, and one study (36) reported that the incidence of ICU admission in the prone position and usual care groups was 75% and 69.23%, respectively. The summary results showed that there is no significant difference between the two groups, OR = 1.20 (95% CI: 0.66–2.19; P = 0.55; I2 = 0%) as shown in Figure S5 in Supplementary material. I2 = 0% indicated low heterogeneity.
Adverse events
Nine RCTs (20–23, 35–39) including 3,067 patients reported adverse events in the prone position and usual care groups, no adverse events were reported in both groups by Jayakumar et al. (37), and no serious adverse events were reported in all studies. The results showed that there is no significant difference in the incidence of adverse events between the two groups (Figure S6 in Supplementary material), OR = 1.21 (95% CI: 0.58–2.54; P = 0.61; I2 = 78%). I2 = 78% indicated high heterogeneity.
Publication bias
We used the funnel plot to evaluate the publication bias of several outcomes, including intubation rate, mortality, and ICU admission. The results showed that there is no significant publication bias in the intubation rate and incidence ICU admission rate (Figures S7, S8 in Supplementary material), but there may be publication bias in mortality (Figure S9 in Supplementary material).
Discussion
Out of all the people hospitalized with COVID-19, 15–30% will go on to develop COVID-19-associated acute respiratory distress syndrome (42). In the supine position, pleural pressure develops along a vertical gradient from the non-dependent to the dependent chest, which is magnified in patients with ARDS (43). Therefore, it is beneficial to carry out the prone position for patients with ARDS.
Our systematic review and meta-analysis confirmed that awake prone position improved oxygenation in COVID-19 patients with ARDS or AHRF significantly compared with usual care, which is consistent with the results of Fazzini et al. (18). The results also found that prone position can reduce the need for intubation, which is consistent with the results of three recent studies (16, 17, 44), but contradicts the results of Fazzini et al. (18), and the reason for this contradiction may be that they have included a large number of observational studies. Although the awake prone position has these advantages, there is likely substantial variation in actual patient adherence and tolerability of the technique. In addition, considering the high risk of clinical deterioration of patients with COVID-19, the awake prone position should be conducted when the patients are in a monitoring state to avoid delaying the timing of intubation (45).
A recent meta-analysis by Weatherald et al. (46) shows that the awake prone position can reduce the need for the intubation of patients with ARDS or AHRF caused by COVID-19, this is consistent with our results, and our subgroup analysis of the intubation rate according to the average time of prone position per day (< 8 h or >8 h), and ICU vs. non-ICU, there was no significant difference between the two groups. Moreover, subgroup analysis of the intubation rate according to oxygen delivery found that the advantage of significantly reducing intubation in the awake prone position was mainly shown in patients receiving HFNC or NIV. The reason may be because patients receiving HFNC or NIV had more severe diseases and greater possibility to progress to endotracheal intubation than patients receiving COT. Weatherald et al. thought that the awake prone position did not significantly improve the oxygenation outcomes; however, by comparing the oxygenation outcomes of patients with COVID-19 before and after the prone position, as well as the oxygenation results of the awake prone position group and usual care group, we found that awake prone position significantly improved the SpO2/FiO2 ratio of patients with COVID-19. The difference between the two studies may be caused by the heterogeneity of the included studies.
We tried to evaluate the oxygenation outcomes with subgroup analysis according to the average time of prone position, the oxygen delivery methods, and ICU vs. non-ICU, but the existing data do not support us to do so because the number of studies in each group is not enough. All RCTs involved in this meta-analysis showed that the prone position could improve oxygenation in patients with COVID-19 with ARDS or AHRF. The possible mechanisms may be as follows: (i) The prone position reduced the compression of the heart and mediastinum and recruitment of the lungs below the heart, thus improving ventilation (47, 48). (ii) Prone position can reduce the gradient of pleural pressure from the independent area to the dependent region, and make the lung aeration and strain distribution more homogeneous (49–51). The results of a single-center RCT (52) showed that it is beneficial to prolong the prone position of patients with COVID-19. The results of Kaur et al. (53) indicated that the early conscious prone position can reduce mortality in patients with COVID-19 with ARDS or AHRF, which was similar to our results. The research by Vetrugno et al. (54) found that invasive mechanical ventilation increased the risk of barotrauma compared with high-flow nasal oxygen. Therefore, it is meaningful to reduce the intubation rate of patients, and the prone position may help to reduce the barotrauma of patients with ARDS.
Except for two studies (34, 39), other RCTs included in this meta-analysis showed that the prone position could reduce the need for intubation in patients with COVID-19. This finding is of great significance. First, as the number of patients with COVID-19 increases, reducing the need for intubation can alleviate the shortage of medical resources and pressure on the ICU, as well as reduce the risk of aerosol-borne diseases during endotracheal intubation. Second, prolonged intubation may be associated with an increase in mortality (55). Therefore, it is necessary to reduce intubation under the premise of closely observing the progress of the disease. The effect of the prone position may be time-dependent and phase-dependent (56). The subgroup analysis of Kang et al. (17) showed that the intubation rate decreased more significantly in the group with longer prone time. Li et al. (16) found that the prone position has no effect on ICU patients, as the prone position is difficult to reduce the intubation rate of serious patients. However, in our RCTs-based study, there was no difference in intubation rates between the two groups in two subgroup analyses (< 8 h or >8 h; ICU vs. non-ICU).
No significant difference in mortality, hospital LOS, incidence of ICU admission, and adverse events between the prone position and usual care was found in this meta-analysis. This may be caused by almost all studies evaluating them as secondary results or insufficient follow-up time for the patient. In addition, the compliance of patients and the guidance of medical staff may also have an impact on the results. The results of mortality may be affected by publication bias.
Strengths and limitations
We believed that our study had several following advantages. First, our study evaluates all comparable clinical outcomes comprehensively. Second, we only included RCT studies because the level of evidence of the original study was higher and the results were more convincing.
However, there were also some limitations in our study. Due to the particularity of the awake prone position intervention, some studies were unable to the allocation concealment and blinding of participants or outcome assessment, which may increase the potential risk of bias. In all studies, the start time, duration, and oxygen delivery mode of the prone position were not consistent, which may affect the results. In addition, all studies only reported the results of short-term follow-up, and the long-term prognosis of the patients was unknown. More high-quality RCT studies are needed to analyze the oxygenation outcomes and determine the best start time, duration, and population of prone position in future research. In addition, it is very important to strengthen the guidance to patients and improve their compliance in the prone position for a long time. Future studies should extend the follow-up time and report the long-term prognosis. The effects of related factors such as the degree of dyspnea and the severity of the disease on the results of the study need to be further studied.
Conclusion
The awake prone position is a promising method for COVID-19 patients with acute hypoxic respiratory failure, with potential benefits including improved oxygenation and intubation rate. There was no significant difference in mortality, hospital length of stay, incidence of ICU admission, and adverse events between the prone position and usual care groups.
Data availability statement
The original contributions presented in the study are included in the article/Supplementary material, further inquiries can be directed to the corresponding authors.
Author contributions
QP and SY: protocol/project development, methodology, validation, software, data curation, formal analysis, resources, and writing—original draft. YZ, WZ, MH, BM, HN, and LM: visualization, software, data curation, and formal analysis. LZ, YW, and JY: conceptualization, protocol/project development, visualization, supervision, project administration, funding acquisition, writing—review and editing, and substantial contributions to the conception or design of the work. All the authors are agreed and approved the final manuscript for publication.
Funding
This study is supported by National Natural Science Foundation of China (82172462), Traditional Chinese Medicine Science and Technology Development Plan Project of Jiangsu Province (YB2020085), and Key Projects of Social development of Yangzhou City (YZ2021083).
Acknowledgments
The authors would like to acknowledge the Clinical Medical College of Yangzhou University and Northern Jiangsu People's Hospital.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fmed.2023.1120837/full#supplementary-material
References
1. Nasa P, Azoulay E, Khanna AK, Jain R, Gupta S, Javeri Y, et al. Expert consensus statements for the management of COVID-19-related acute respiratory failure using a Delphi method. Crit Care. (2021) 25:106. doi: 10.1186/s13054-021-03491-y
2. Neto AS, Checkley W, Sivakorn C, Hashmi M, Papali A, Schultz MJ, et al. Pragmatic recommendations for the management of acute respiratory failure and mechanical ventilation in patients with COVID-19 in low- and middle-income countries. Am J Trop Med Hyg. (2021) 104:60–71. doi: 10.4269/ajtmh.20-0796
3. Scaravilli V, Grasselli G, Castagna L, Zanella A, Isgrò S, Lucchini A, et al. Prone positioning improves oxygenation in spontaneously breathing nonintubated patients with hypoxemic acute respiratory failure: a retrospective study. J Crit Care. (2015) 30:1390–4. doi: 10.1016/j.jcrc.2015.07.008
4. Ding L, Wang L, Ma W, He H. Efficacy and safety of early prone positioning combined with HFNC or NIV in moderate to severe ARDS: a multi-center prospective cohort study. Crit Care. (2020) 24:28. doi: 10.1186/s13054-020-2738-5
5. Longhini F, Bruni A, Garofalo E, Navalesi P, Grasselli G, Cosentini R, et al. Helmet continuous positive airway pressure and prone positioning: a proposal for an early management of COVID-19 patients. Pulmonology. (2020) 26:186–91. doi: 10.1016/j.pulmoe.2020.04.014
6. Guérin C, Reignier J, Richard JC, Beuret P, Gacouin A, Boulain T, et al. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med. (2013) 368:2159–68. doi: 10.1056/NEJMoa1214103
7. Guérin C, Albert RK, Beitler J, Gattinoni L, Jaber S, Marini JJ, et al. Prone position in ARDS patients: why, when, how and for whom. Intensive Care Med. (2020) 46:2385–96. doi: 10.1007/s00134-020-06306-w
8. Richter T, Bellani G, Harris RS, Melo MFV, Winkler T, Venegas JG, et al. Effect of prone position on regional shunt, aeration, and perfusion in experimental acute lung injury. Am J Respir Crit Care Med. (2005) 172:480–7. doi: 10.1164/rccm.200501-004OC
9. Paul V, Patel S, Royse M, Odish M, Malhotra A, Koenig S. Proning in non-intubated (PINI) in times of COVID-19: case series and a review. J Intensive Care Med. (2020) 35:818–24. doi: 10.1177/0885066620934801
10. Kallet RH. A comprehensive review of prone position in ARDS. Respir Care. (2015) 60:1660–87. doi: 10.4187/respcare.04271
11. Cammarota G, Rossi E, Vitali L, Simonte R, Sannipoli T, Anniciello F, et al. Effect of awake prone position on diaphragmatic thickening fraction in patients assisted by noninvasive ventilation for hypoxemic acute respiratory failure related to novel coronavirus disease. Crit Care. (2021) 25:305. doi: 10.1186/s13054-021-03735-x
12. Weiss TT, Cerda F, Scott JB, Kaur R, Sungurlu S, Mirza SH, et al. Prone positioning for patients intubated for severe acute respiratory distress syndrome (ARDS) secondary to COVID-19: a retrospective observational cohort study. Br J Anaesth. (2021) 126:48–55. doi: 10.1016/j.bja.2020.09.042
13. Langer T, Brioni M, Guzzardella A, Carlesso E, Cabrini L, Castelli G, et al. Prone position in intubated, mechanically ventilated patients with COVID-19: a multi-centric study of more than 1000 patients. Crit Care. (2021) 25:128. doi: 10.1186/s13054-021-03552-2
14. Coppo A, Bellani G, Winterton D, Di Pierro M, Soria A, Faverio P, et al. Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study. Lancet Resp Med. (2020) 8:765–74. doi: 10.1016/S2213-2600(20)30268-X
15. Park J, Lee HY, Lee J, Lee S-M. Effect of prone positioning on oxygenation and static respiratory system compliance in COVID-19 ARDS vs. non-COVID ARDS. Respir Res. (2021) 22:220. doi: 10.1186/s12931-021-01819-4
16. Li J, Luo J, Pavlov I, Perez Y, Tan W, Roca O, et al. Awake prone positioning for non-intubated patients with COVID-19-related acute hypoxaemic respiratory failure: a systematic review and meta-analysis. Lancet Resp Med. (2022) 10:573–83. doi: 10.1016/S2213-2600(22)00164-3
17. Kang H, Gu X, Tong Z. Effect of awake prone positioning in non-intubated COVID-19 patients with acute hypoxemic respiratory failure: a systematic review and meta-analysis. J Intensive Care Med. (2022) 37:1493–503. doi: 10.1177/08850666221121593
18. Fazzini B, Page A, Pearse R, Puthucheary Z. Prone positioning for non-intubated spontaneously breathing patients with acute hypoxaemic respiratory failure: a systematic review and meta-analysis. Br J Anaesth. (2022) 128:352–62. doi: 10.1016/j.bja.2021.09.031
19. Chong WH, Saha BK, Tan CK. Clinical outcomes of routine awake prone positioning in COVID-19 patients: a systematic review and meta-analysis of randomized controlled trials. Prague Med Rep. (2022) 123:140–65. doi: 10.14712/23362936.2022.14
20. Agarwal A, Martin GS. In COVID-19 acute hypoxemia, awake prone positioning vs. usual care did not reduce intubation at 30 d. Ann Intern Med. (2022) 175:JC99. doi: 10.7326/J22-0068
21. Alhazzani W, Parhar KKS, Weatherald J, Duhailib ZA, Alshahrani M, Al-Fares A, et al. Effect of awake prone positioning on endotracheal intubation in patients with COVID-19 and acute respiratory failure: a randomized clinical trial. JAMA. (2022) 327:2104–13. doi: 10.1001/jama.2022.7993
22. Rampon G, Jia S, Agrawal R, Arnold N, Martín-Quir?s A, Fischer EA, et al. Smartphone-guided self-prone positioning vs usual care in nonintubated hospital ward patients with COVID-19: a pragmatic randomized clinical trial. Chest. (2022) 162:782–91. doi: 10.1016/j.chest.2022.05.009
23. Ibarra-Estrada M, Li J, Pavlov I, Perez Y, Roca O, Tavernier E, et al. Factors for success of awake prone positioning in patients with COVID-19-induced acute hypoxemic respiratory failure: analysis of a randomized controlled trial. Crit Care. (2022) 26:84. doi: 10.1186/s13054-022-03950-0
24. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. (2021) 372:n71. doi: 10.1136/bmj.n71
25. Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. (2015) 350:g7647. doi: 10.1136/bmj.g7647
26. Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. (2011) 343:d5928. doi: 10.1136/bmj.d5928
27. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. (2005) 5:13. doi: 10.1186/1471-2288-5-13
28. Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res. (2018) 27:1785–805. doi: 10.1177/0962280216669183
29. Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Chapter 6: Choosing effect measures and computing estimates of effect. In:Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al., , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane (2022).
30. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. (2003) 327:557–60. doi: 10.1136/bmj.327.7414.557
31. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods. (2010) 1:e12. doi: 10.1002/jrsm.12
32. Gad GS. Awake prone positioning versus non-invasive ventilation for COVID-19 patients with acute hypoxemic respiratory failure. Egyptian J Anaesth. (2021) 37:85–90. doi: 10.1080/11101849.2021.1889944
33. Kharat A, Dupuis-Lozeron E, Cantero C, Marti C, Grosgurin O, Lolachi S, et al. Self-proning in COVID-19 patients on low-flow oxygen therapy: a cluster randomised controlled trial. ERJ Open Res. (2021) 7:3670. doi: 10.1183/13993003.congress-2021.PA3670
34. Johnson SA, Horton DJ, Fuller MJ, Yee J, Aliyev N, Boltax JP, et al. Patient-directed prone positioning in awake patients with COVID-19 requiring hospitalization (PAPR). Ann Am Thorac Soc. (2021) 18:1424–6. doi: 10.1513/AnnalsATS.202011-1466RL
35. Taylor SP, Bundy H, Smith WM, Skavroneck S, Taylor B, Kowalkowski MA. Awake prone positioning strategy for nonintubated hypoxic patients with COVID-19: a pilot trial with embedded implementation evaluation. Ann Am Thorac Soc. (2021) 18:1360–8. doi: 10.1513/AnnalsATS.202009-1164OC
36. Rosén J, von Oelreich E, Fors D, Fagerlund MJ, Taxbro K, Skorup P, et al. Awake prone positioning in patients with hypoxemic respiratory failure due to COVID-19: the PROFLO multicenter randomized clinical trial. Crit Care. (2021) 25:209. doi: 10.1186/s13054-021-03602-9
37. Jayakumar D, Dnb PR, Dnb ER, Md BKTV, Ab NR, Ab RV. Standard care versus awake prone position in adult nonintubated patients with acute hypoxemic respiratory failure secondary to COVID-19 infection—a multicenter feasibility randomized controlled trial. J Intensive Care Med. (2021) 36:918–24. doi: 10.1177/08850666211014480
38. Ehrmann S, Li J, Ibarra-Estrada M, Perez Y, Pavlov I, McNicholas B, et al. Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial. Lancet Resp Med. (2021) 9:1387–95. doi: 10.1016/S2213-2600(21)00356-8
39. Fralick M, Colacci M, Munshi L, Venus K, Fidler L, Hussein H, et al. Prone positioning of patients with moderate hypoxaemia due to covid-19: multicentre pragmatic randomised trial (COVID-PRONE). BMJ. (2022) 376:e068585. doi: 10.1136/bmj-2021-068585
40. Hashemian SM, Jamaati H, Malekmohammad M, Tabarsi P, Khoundabi B, Shafigh N. Efficacy of early prone positioning combined with noninvasive ventilation in COVID-19. Tanaffos. (2021) 20:82–5.
41. Harris T., R. E. Hamad Medical Corporation. (2022). Awake Prone Positioning in COVID-19 Suspects With Hypoxemic Respiratory Failure. Available online at: https://beta.clinicaltrials.gov/study/NCT04853979 (accessed August 4, 2022).
42. Attaway AH, Scheraga RG, Bhimraj A, Biehl M, Hatipoglu U. Severe COVID-19 pneumonia: pathogenesis and clinical management. BMJ. (2021) 372:n436. doi: 10.1136/bmj.n436
43. Cammarota G, Simonte R, Longhini F, Spadaro S, Vetrugno L, De Robertis E. Advanced point-of-care bedside monitoring for acute respiratory failure. Anesthesiology. (2023) 138:317–34. doi: 10.1097/ALN.0000000000004480
44. Mehta A, Bansal M, Vallabhajosyula S. In COVID-19 acute hypoxemic respiratory failure, awake prone positioning vs. the supine position reduces intubations. Ann Intern Med. (2022) 175:JC81. doi: 10.7326/J22-0050
45. Myatra SN, Alhazzani W, Belley-Cote E, Møller MH, Arabi YM, Chawla R, et al. Awake proning in patients with COVID-19-related hypoxemic acute respiratory failure: A rapid practice guideline. Acta Anaesthesiol Scand. (2023). doi: 10.1111/aas.14205
46. Weatherald J, Parhar KKS, Duhailib ZA, Chu DK, Granholm A, Solverson K, et al. Efficacy of awake prone positioning in patients with covid-19 related hypoxemic respiratory failure: systematic review and meta-analysis of randomized trials. BMJ. (2022) 379:e071966. doi: 10.1136/bmj-2022-071966
47. Wiener CM, McKenna WJ, Myers MJ, Lavender JP, Hughes JM. Left lower lobe ventilation is reduced in patients with cardiomegaly in the supine but not the prone position. Am Rev Respir Dis. (1990) 141:150–5. doi: 10.1164/ajrccm/141.1.150
48. Scholten EL, Beitler JR, Prisk GK, Malhotra A. Treatment of ARDS with prone positioning. Chest. (2017) 151:215–24. doi: 10.1016/j.chest.2016.06.032
49. Henderson AC, Sá RC, Theilmann RJ, Buxton RB, Prisk GK, Hopkins SR, et al. The gravitational distribution of ventilation-perfusion ratio is more uniform in prone than supine posture in the normal human lung. J Appl Physiol. (1985) 115:313–24. doi: 10.1152/japplphysiol.01531.2012
50. Pelosi P, D'Andrea L, Vitale G, Pesenti A, Gattinoni L. Vertical gradient of regional lung inflation in adult respiratory distress syndrome. Am J Respir Crit Care Med. (1994) 149:8111603. doi: 10.1164/ajrccm.149.1.8111603
51. Tawhai MH, Nash MP, Lin C-L, Hoffman EA. Supine and prone differences in regional lung density and pleural pressure gradients in the human lung with constant shape. J Appl Physiol. (1985) 107:912–20. doi: 10.1152/japplphysiol.00324.2009
52. Page DB, Vijaykumar K, Russell DW, Gandotra S, Chiles JW, Whitson MR, et al. Prolonged prone positioning for COVID-19-induced acute respiratory distress syndrome: a randomized pilot clinical trial. Ann Am Thorac Soc. (2022) 19:685–7. doi: 10.1513/AnnalsATS.202104-498RL
53. Kaur R, Vines DL, Mirza S, Elshafei A, Jackson JA, Harnois LJ, et al. Early versus late awake prone positioning in non-intubated patients with COVID-19. Crit Care. (2021) 25:340. doi: 10.1186/s13054-021-03761-9
54. Vetrugno L, Castaldo N, Fantin A, Deana C, Cortegiani A, Longhini F, et al. Ventilatory associated barotrauma in COVID-19 patients: a multicenter observational case control study (COVI-MIX-study). Pulmonology. (2022). doi: 10.1016/j.pulmoe.2022.11.002
55. Kangelaris KN, Ware LB, Wang CY, Janz DR, Zhuo H, Matthay MA, et al. Timing of intubation and clinical outcomes in adults with acute respiratory distress syndrome. Crit Care Med. (2016) 44:120–9. doi: 10.1097/CCM.0000000000001359
Keywords: COVID-19, hypoxemic respiratory failure, ARDS, oxygenation, intubation rate, mortality, awake prone positioning
Citation: Peng Q, Yang S, Zhang Y, Zhao W, Hu M, Meng B, Ni H, Min L, Yu J, Wang Y and Zhang L (2023) Effects of awake prone position vs. usual care on acute hypoxemic respiratory failure in patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials. Front. Med. 10:1120837. doi: 10.3389/fmed.2023.1120837
Received: 13 December 2022; Accepted: 06 March 2023;
Published: 04 April 2023.
Edited by:
Xuerui Wang, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, ChinaReviewed by:
Federico Longhini, University of Magna Graecia, ItalyLuigi Vetrugno, University of Studies G. d'Annunzio Chieti and Pescara, Italy
Prashant Nasa, NMC Specialty Hospital, Al Nahda, United Arab Emirates
Copyright © 2023 Peng, Yang, Zhang, Zhao, Hu, Meng, Ni, Min, Yu, Wang and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Jiangquan Yu, Yujiangquan2021@163.com; Yongxiang Wang, wyx918spine@126.com; Liang Zhang, zhangliang6320@sina.com
†These authors have contributed equally to this work and share first authorship
‡These authors have contributed equally to this work